XML 57 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Equity-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement, Disclosure [Abstract]  
Schedule Equity-Based Compensation Expense
Equity-based compensation expense, which is recorded in Selling and administrative expenses in the Consolidated Statements of Operations was as follows:
Year Ended December 31,
202220212020
Equity-based compensation expense$91.1 $72.6 $42.5 
Income tax benefit(1)
(15.5)(12.2)(7.7)
Equity-based compensation expense, net of tax$75.6 $60.4 $34.8 
(1)Represents equity-based compensation tax expense at the statutory tax rates. Excess tax benefits associated with equity awards are excluded from this disclosure and separately disclosed in Note 10 (Income Taxes).
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The weighted-average assumptions used to value the stock options granted were as follows:
Year Ended December 31,
202220212020
Grant date fair value$43.20 $40.83 $20.46 
Volatility (1)
27.50 %30.00 %25.50 %
Risk-free rate (2)
1.94 %0.93 %0.51 %
Expected dividend yield1.17 %1.03 %1.52 %
Expected term (in years) (3)
6.05.66.0
(1)Based upon an assessment of the two-year and five-year historical and implied volatility for the Company’s selected peer group, adjusted for the Company’s leverage.
(2)Based on a composite US Treasury rate.
(3)Based on contractual term length and on historical experience of both exercised and unexercised options.
Schedule of Stock Options Roll Forward
Stock option activity for the year ended December 31, 2022 was as follows:
OptionsNumber of OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term (years)Aggregate Intrinsic Value
Outstanding at January 1, 2022
3,355,266 $89.76 
Granted600,567 170.79 
Forfeited/Expired(62,713)140.50 
Exercised(1)
(393,819)76.63 
Outstanding at December 31, 2022
3,499,301 $104.23 6.07$260.5 
Vested and exercisable at December 31, 2022
2,256,541 $79.30 4.93$224.1 
Expected to vest after December 31, 2022
1,226,577 $149.35 8.13$36.1 
(1)The total intrinsic value of stock options exercised during the years ended December 31, 2022, 2021 and 2020 was $40 million, $117 million and $94 million, respectively.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
RSU activity for the year ended December 31, 2022 was as follows:
Number of UnitsWeighted-Average Grant-Date Fair Value
Non-vested at January 1, 2022
437,524 $163.82 
Granted (1)
124,683 169.11 
Vested (2)
(102,078)153.23 
Forfeited(28,069)178.12 
Non-vested at December 31, 2022
432,060 $166.92 
(1)The weighted-average grant date fair value of RSUs granted during the years ended December 31, 2022, 2021 and 2020 was $169.11, $172.96 and $112.55, respectively.
(2)The aggregate fair value of RSUs that vested during the years ended December 31, 2022, 2021 and 2020 was $16 million, $2 million and $12 million, respectively.
Schedule of Nonvested Performance-based Units Activity
PSU activity for the year ended December 31, 2022 was as follows:
Number of UnitsWeighted-Average Grant-Date Fair Value
Non-vested at January 1, 2022
387,204 $123.05 
Granted (1)
308,263 176.14 
Attainment adjustment (2)
81,573 96.00 
Vested (3)
(278,115)100.82 
Forfeited(54,692)153.29 
Non-vested at December 31, 2022
444,233 $165.11 
(1)The weighted-average grant date fair value of PSUs granted during the years ended December 31, 2022, 2021 and 2020 was $176.14, $154.37 and $102.96, respectively.
(2)During the year ended December 31, 2022, the attainment on PSUs vested at December 31, 2021 was adjusted to reflect actual performance.
(3)The aggregate fair value of PSUs that vested during the years ended December 31, 2022, 2021 and 2020 was $28 million, $28 million and $24 million, respectively.